Uniphar

H1 trading statement reflects strong operating performance

  • Sectors : Pharma and healthcare
  • Companies : Uniphar

Ratings and price correct at time of issue.

  • Uniphar

    Closing Price: 302c

  • RATING 27/08/19

  • PREVIOUS RATING N/A

DAVY VIEW

Uniphar’s H1 trading statement confirms that the business is performing very well and that the company is likely to achieve around 15% growth in EBITDA this year. Rising interest charges provide a modest headwind to EPS. New medium-term targets will be announced with the interims on September 14th.

Download full report with analyst certification and important disclosures

Jul 26 2023, 07:10 IST/BST

Download